These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Pathology and pathogenesis of rheumatic heart disease. Chopra P; Gulwani H Indian J Pathol Microbiol; 2007 Oct; 50(4):685-97. PubMed ID: 18306530 [TBL] [Abstract][Full Text] [Related]
6. Group G Streptococcus Induces an Autoimmune Carditis Mediated by Interleukin 17A and Interferon γ in the Lewis Rat Model of Rheumatic Heart Disease. Sikder S; Williams NL; Sorenson AE; Alim MA; Vidgen ME; Moreland NJ; Rush CM; Simpson RS; Govan BL; Norton RE; Cunningham MW; McMillan DJ; Sriprakash KS; Ketheesan N J Infect Dis; 2018 Jun; 218(2):324-335. PubMed ID: 29236994 [TBL] [Abstract][Full Text] [Related]
7. Inactivation of the Rgg2 transcriptional regulator ablates the virulence of Streptococcus pyogenes. Zutkis AA; Anbalagan S; Chaussee MS; Dmitriev AV PLoS One; 2014; 9(12):e114784. PubMed ID: 25486272 [TBL] [Abstract][Full Text] [Related]
8. Differential secretomics of Streptococcus pyogenes reveals a novel peroxide regulator (PerR)-regulated extracellular virulence factor mitogen factor 3 (MF3). Wen YT; Tsou CC; Kuo HT; Wang JS; Wu JJ; Liao PC Mol Cell Proteomics; 2011 Sep; 10(9):M110.007013. PubMed ID: 21636680 [TBL] [Abstract][Full Text] [Related]
9. Label-free proteomic analysis of environmental acidification-influenced Streptococcus pyogenes secretome reveals a novel acid-induced protein histidine triad protein A (HtpA) involved in necrotizing fasciitis. Wen YT; Wang JS; Tsai SH; Chuan CN; Wu JJ; Liao PC J Proteomics; 2014 Sep; 109():90-103. PubMed ID: 24998435 [TBL] [Abstract][Full Text] [Related]
10. An immunological perspective on rheumatic heart disease pathogenesis: more questions than answers. Bright PD; Mayosi BM; Martin WJ Heart; 2016 Oct; 102(19):1527-32. PubMed ID: 27260192 [TBL] [Abstract][Full Text] [Related]
11. Repeat exposure to group A streptococcal M protein exacerbates cardiac damage in a rat model of rheumatic heart disease. Gorton D; Sikder S; Williams NL; Chilton L; Rush CM; Govan BL; Cunningham MW; Ketheesan N Autoimmunity; 2016 Dec; 49(8):563-570. PubMed ID: 27562362 [TBL] [Abstract][Full Text] [Related]
12. A vaccine against Streptococcus pyogenes: the potential to prevent rheumatic fever and rheumatic heart disease. Guilherme L; Ferreira FM; Köhler KF; Postol E; Kalil J Am J Cardiovasc Drugs; 2013 Feb; 13(1):1-4. PubMed ID: 23355360 [TBL] [Abstract][Full Text] [Related]
13. Immune response against M protein-conserved region peptides from prevalent group A Streptococcus in a North Indian population. Gupta VK; Sekhar S; Dhanda V; Toor D; Kumar R; Chakraborti A J Microbiol Immunol Infect; 2016 Jun; 49(3):352-8. PubMed ID: 25087198 [TBL] [Abstract][Full Text] [Related]
14. Rheumatic fever: how S. pyogenes-primed peripheral T cells trigger heart valve lesions. Guilherme L; Faé KC; Oshiro SE; Tanaka AC; Pomerantzeff PM; Kalil J Ann N Y Acad Sci; 2005 Jun; 1051():132-40. PubMed ID: 16126952 [TBL] [Abstract][Full Text] [Related]
15. Group A streptococcal M-protein specific antibodies and T-cells drive the pathology observed in the rat autoimmune valvulitis model. Sikder S; Price G; Alim MA; Gautam A; Scott Simpson R; Margaret Rush C; Lee Govan B; Ketheesan N Autoimmunity; 2019 Mar; 52(2):78-87. PubMed ID: 31062619 [TBL] [Abstract][Full Text] [Related]
16. Induction of autoimmune valvulitis in Lewis rats following immunization with peptides from the conserved region of group A streptococcal M protein. Lymbury RS; Olive C; Powell KA; Good MF; Hirst RG; LaBrooy JT; Ketheesan N J Autoimmun; 2003 May; 20(3):211-7. PubMed ID: 12753806 [TBL] [Abstract][Full Text] [Related]